Tutorial 4 - Cancer & cell death Flashcards
2 types of hallmarks of cancer?
Emerging (newly discovered) and underlying
Emerging hallmarks of cancer?
- reprogramming of energy metabolism
- evasion of destruction by immune system
Underlying hallmarks of cancer?
- genetic instability
- inflammation
how are cancer cells involved with sustaining proliferative signalling?
- produce own growth factors
- induce surrouding normal cells to produce growth factors
- signaling can be deregulated (by cancer cells, intentionally) by increased expression of growth receptors (ie. HER2 overexpression)
how are cancer cells involved with evading growth suppressors?
- inactivation tumor suppressor genes (RB and tp53)
- disables body ability to induce normal senescence and apoptosis
how are cancer cells involved with resisting cell death?
- loss of tp53 (which induces apoptosis)
- increased expression of anti-apoptotic factors
- down regulate pro-apoptotic factors (Bax, Bim)
how are cancer cells involved with enabling replicative immortality?
- overexpression of telomerase enzyme to lengthen telomeres, thereby avoiding senescence or apoptosis
how are cancer cells involved with inducing angiogenesis?
- VEGF-a (its expression being upregulated by hypoxia and oncogene signalling)
- peri-tumoral inflammatory cells help induce angiogenesis
how are cancer cells involved with activating invasion and metastasis?
- Local invasion by cancer cells, breakdown of ECM
- Intravasation (BV and lymphatics)
- Extravasation (into distant tissues)
- Micro-metastases (small nodule formation)
- Colonization (growth of micro-metastatic lesions into tumors)
Cancer cells undergo invasion and metastasis. What is EMT, and how does it relate to this?
Epithelial-Mesenchymal transition:
- process by which epithelial cells lose polarity, gain migratory and invasive properties, become mesenchymal stem cells (multipotent)
- cancer cells undergo EMT(?), this augments their ability to invade/ resist apoptosis/ disseminate
- basically makes cells become much more motile
what orchestrates EMT?
transcription factors (Snail, slug, twist)
to go from epithelial to mesenchymal state, what process is required?
EMT!
how are cancer cells involved with deregulating cellular metabolism?
- use glycolysis instead of oxidative phos.
- 18 fold less efficient, but provides intermediates (nucleoslides, amino acids) needed for rapidly dividing cells
normal cell:
a. ) what % oxidative phos.?
b. ) what % glycolysis?
a. ) 90%
b. ) 10%
cancer cell:
a. ) what % oxidative phos.?
b. ) what % glycolysis?
a. ) 40%
b. ) 60%
how are cancer cells involved with avoiding immune destruction?
- highly immunogenic cancer cells destroyed (immuno-editing)
- lowly immunogenic cancer cells survive, these variants grow and generate tumors
how are cancer cells involved with genome instability and mutation?
- tp53 mutation
- DNA mismatch repair defects
- this disables detection DNA damage, activation repair machinery etc.
how do inflammatory cells contribute to hallmark capabilities of cancer?
By releasing…
• growth factors that sustain proliferative signalling
• survival factors that limit cell death
• pro-angiogenic factors
• matrix-modifying enzymes that facilitate invasion, and metastasis
• inductive signals that lead to activation of EMT
• reactive oxygen species that are actively mutagenic for cancer cells
state the therapeutic means of targeting the following cancer hallmark: sustaining proliferative signalling
EGFR inhibitors
state the therapeutic means of targeting the following cancer hallmark: evading growth suppressors
Cyclin dependent kinase inhibitors
state the therapeutic means of targeting the following cancer hallmark: avoiding immune destruction
immune-activating anti-CTLA4 mAb
state the therapeutic means of targeting the following cancer hallmark: enabling replicative immortality
telomerase inhibitors
state the therapeutic means of targeting the following cancer hallmark: tumor promiting inflammation
anti-inflammatory drugs
state the therapeutic means of targeting the following cancer hallmark: invasion and metastasis
inhibitors of MET
state the therapeutic means of targeting the following cancer hallmark: inducing angiogenesis
VEGF inhibitors